胆固醇分析显示,7β-基胆固醇是阿尔茨海默病的病理相关的外周生物标志物
Junghee Ha1, Go Eun Kwon2, Yumi Son1,3
1Department of Psychiatry, Laboratory for Alzheimer's Molecular Psychiatry, Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Psychiatry and clinical neurosciences
|June 26, 2024
概括
升高的7β-基胆固醇 (OHC) 水平与阿尔茨海默病 (AD) 的进展和认知能力下降有关. 这种胆固醇代谢物可以作为阿尔茨海默病的外周生物标志物,并作为个性化他类药物治疗的标.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 代谢学 代谢学 代谢学
背景情况:
- 胆固醇平衡与阿尔茨海默氏症 (AD) 病原发生有关.
- 参与阿尔茨海默病的特定胆固醇代谢物及其生物标志物潜力在很大程度上是未知的.
研究的目的:
- 为了确定与AD相关的关键胆固醇代谢物.
- 研究7β-基胆固醇 (OHC) 在AD病变和认知功能中的作用.
主要方法:
- 在老化/转基因小鼠和人类队伍中使用气色谱-质谱分析进行类固醇分析 (认知,MCI,AD).
- 在小鼠体内注射7β-OHC,以评估其对AD病理和行为的影响.
- 分子,组织病理和行为评估 (对象识别,5个选择串行反应时间任务).
主要成果:
- 与正常小鼠相比,3xTg-AD小鼠的血清7β-OHC水平随着衰老而增加.
- 在AD患者的头发中增加7β-OHC,与临床严重程度相关.
- 内7β-OHC诱导的神经炎症 (星细胞/微细胞激活,促炎细胞因子) 和增强的粉胺基因通路.
- 在小鼠中,7β-OHC的使用损害了记忆和执行功能.
结论:
- 7β-基胆固醇 (OHC) 显示出作为阿尔茨海默病 (AD) 的一个方便的外围生物标志物的潜力.
- OHC直接参与AD的发病,这表明它在疾病进展中的作用.
- OHC测定可以促进个性化医疗,识别个人用于基于他类药物的AD治疗.
相关概念视频
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
Cholesterol: Significance and Regulation
535
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
535
Alzheimer's Disease: Treatment
178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178


